Crosslands Cancer Center

Effingham, Illinois 62401

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Colorectal Cancer

Studies at this site

• Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status — Status unconfirmed